Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Dennis Kraus"'
Autor:
Jeffrey Chi, Isabel R Preeshagul, Silvat Sheikh-Fayyaz, Sewit Teckie, Nina Kohn, Yonah Ziemba, Alice Laser, Douglas Frank, Maged Ghaly, Dev Kamdar, Dennis Kraus, Doru Paul, Nagashree Seetharamu
Publikováno v:
Future Science OA, Vol 6, Iss 9 (2020)
Aim: Current guidelines recommend p16 immunohistochemistry (IHC) for testing human papillomavirus (HPV) in oropharyngeal carcinoma (OPSCC). We evaluated the value of adding DNA in situ hybridization (ISH) to p16 IHC. Methods: Fifty patients with OPSC
Externí odkaz:
https://doaj.org/article/ae08b2e8b9084391b8c0f14ec3173d9e
Autor:
James C. Gates, Allison P. Clark, Elliot Cherkas, Aditya V. Shreenivas, Dennis Kraus, Natalie Danzinger, Richard S. P. Huang, Jennifer Johnson, Jeffrey S. Ross
Publikováno v:
Head & Neck. 45:816-826
Autor:
Dennis Kraus, Michael J. Link
Publikováno v:
Journal of Neurological Surgery Part B: Skull Base.
Publikováno v:
Head & Neck. 43:3608-3617
BACKGROUND This systematic review and meta-analysis sought to assess the extent to which pretreatment depression or depressive symptoms are related to prognosis in patients with head and neck cancer (HNC). METHODS Medline, EMbase, Scopus, and The Coc
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 79:1970-1976
Background Recently, histologic grade was removed from salivary tumor nomenclature by the WHO to include disease of higher grade. One such entity, cribriform adenocarcinoma (CAC), is an aggressive group of polymorphous adenocarcinoma (PAC), with freq
Autor:
Dennis Kraus, Barak Ringel
Publikováno v:
Otolaryngologic Clinics of North America. 54:593-604
Surgery is the preferred treatment of benign parotid lesions, but it carries a risk of complications. Therefore, the approach toward the surgery of these lesions should seek to avoid complications. There are no guidelines or recommendations for when
Publikováno v:
Head & Neck. 43:2869-2875
BACKGROUND Medical litigation is different than it was 20 years ago due to changes in health care. This study provides an updated analysis of oral cavity malpractice litigation from the past two decades (2000-2010 and 2011-2019). METHODS Verdict revi
Autor:
Dennis Kraus, Yonghua Ling, Hua Yang, Heidi Mangus, Feng Yin, Jennifer Keller, Guowen Liu, Rohini Narayanaswamy, Fumin Li
Publikováno v:
Bioanalysis. 12:1149-1159
Aim: 2-Hydroxyglutarate (2-HG) is a target engagement biomarker in patients after treatment with inhibitors of mutated isocitrate dehydrogenase (mIDH). Accurate measurement of 2-HG is critical for monitoring the inhibition effectiveness of the inhibi
Publikováno v:
The Laryngoscope. 131:333-341
OBJECTIVE To determine whether radiologically defined sarcopenia at the C3 or L3 level as measured by computed tomography or magnetic resonance imaging is prognostic of overall survival (OS) in head and neck cancers (HNCs). METHODS Literature searche
Autor:
Siyu Liu, Emily Bellile, Ariane Nguyen, Katie Zarins, Nisha D'Silva, Laura Rozek, Gregory T. Wolf, Maureen A. Sartor, Jeff Moyer, Mihir Patel, Audrey Erman, Wanessa A. Martins, Jason Newman, Michael Kaplan, Frabicio Oliveira, Ana Paula Victorina, R. Bryan Bell, Gustavo C. Girotto, Jorge Nieva, Joseph Valentino, Greg Krempl, Claudio R. Cernea, Dennis Kraus, Kevin Higgins, Felipe J.S.M. Cruz, Aru Panwar, Clodoaldo Z. Campos, Jim McCaul
Publikováno v:
Oral Oncol
Objective IRX-2 is a homologous cell-derived multi-cytokine biologic with multifaceted immune modulatory effects that has been shown to induce increased lymphocyte infiltration into primary tumors in oral cavity carcinoma. Our objective was to charac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd9a2ea449b58a67dc3dd94769d3b0f
https://europepmc.org/articles/PMC8982160/
https://europepmc.org/articles/PMC8982160/